Article

Custom RX initiates voluntary recall of trypan blue

Custom RX Compounding Pharmacy, of Richfield, MN, said it initiated a nationwide recall of trypan blue 0.06% ophthalmic solution, which may be contaminated with Pseudomonas aeruginosa. Use of trypan blue should stop immediately; if applied to eyes, the bacteria could cause serious injury, even blindness, the pharmacy said in a prepared statement posted on the FDA’s Web site.

Custom RX Compounding Pharmacy, of Richfield, MN, said it initiated a nationwide recall of trypan blue 0.06% ophthalmic solution, which may be contaminated with Pseudomonas aeruginosa. Use of trypan blue should stop immediately; if applied to eyes, the bacteria could cause serious injury, even blindness, the pharmacy said in a prepared statement posted on the FDA’s Web site.

Trypan blue, which is packaged in 1-ml sterile tuberculin syringes, was distributed in hospitals and clinics in Maryland, Minnesota, Illinois, Nebraska, North Dakota, Michigan, District of Columbia, and Pennsylvania. The recall includes, but may not be limited to, the following lot numbers: 05042005:86@17, 05252005:36@13, 06282005:91@27, 08012005:63@24, and 08182005:43@17.

Custom RX Compounding Pharmacy is asking that all unexpired syringes be collected and returned to the pharmacy. The pharmacy said it voluntarily recalled the products based on two reports of loss of vision possibly associated with use of the product as reported by the Centers for Disease Control and Prevention and a positive bacterial culture obtained at an outside hospital.

For more details, ophthalmic professionals are asked to contact the pharmacy at 612/866-2211.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.